MedicalResearch.com Interview with:
Eugene Yu-Chuan Kang, MD.
Department of Ophthalmology
Chang Gung Memorial Hospital
Chang Gung University, School of Medicine
MedicalResearch.com: What is the background for this study?
Response: More and more patients suffered from diabetes mellitus (DM) around the world, as well diabetic complications such as diabetic retinopathy (DR). DR is one of the major causes of blindness in working-age adults. In addition to the cost of treatment for patients with advanced DR, loss of visual function also yields a great burden to the family and society. For advanced DR, surgical interventions such as retinal laser, intravitreal injection, and vitrectomy are needed. However, those surgical interventions for severe DR can only retard or stop disease progression. If DR can be prevented or slowed by medical treatments, the burden of medical costs for treating severe DR may be decreased.
Statin, an HMG-CoA reductase inhibitor, was discussed frequently in the recent years. Multiple functions of statins besides their lipid lowering effect were discovered. Previous investigations have reported that statin therapy could reduce mortality rate and decrease risk of cardiovascular diseases.
In our study, we wanted to figure out if statin therapy may have any association between diabetic retinopathy. Continue reading